KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Investing Activities (2016 - 2025)

Astrana Health (ASTH) has disclosed Cash from Investing Activities for 16 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 96.83% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$539.0 million through Dec 2025, down 180.15% year-over-year, with the annual reading at -$539.0 million for FY2025, 180.15% down from the prior year.
  • Cash from Investing Activities hit -$1.1 million in Q4 2025 for Astrana Health, up from -$534.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $39.1 million in Q4 2021 to a low of -$534.5 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$39.4 million across 5 years, with a median of -$9.3 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: soared 173.38% in 2021 and later tumbled 6492.71% in 2025.
  • Year by year, Cash from Investing Activities stood at $39.1 million in 2021, then plummeted by 66.22% to $13.2 million in 2022, then plummeted by 186.56% to -$11.4 million in 2023, then crashed by 191.63% to -$33.3 million in 2024, then soared by 96.83% to -$1.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ASTH at -$1.1 million in Q4 2025, -$534.5 million in Q3 2025, and -$1.1 million in Q2 2025.